HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers.

Abstract
Two-hundred and six cases of hypopharyngeal and laryngeal squamous cell carcinoma treated at the Institut Gustave-Roussy were retrospectively analyzed. All of them were treated by surgery and they were divided into three therapeutic groups following the adjuvant radiotherapy: (A) Postoperative radiotherapy at doses equal to or greater than 4500 rad; (B) Postoperative radiotherapy at doses less than 4500 rad; and (C) Preoperative irradiation at doses less than 4500 rad. Group A included a greater proportion of patients with hypopharyngeal cancer and patients with advanced tumors (T3, T4; N1b, N2, N3). However, the local and regional control rate in this group is significantly higher than those of the other groups in spite of the poor prognostic factors. The survival rate is comparable in all the three groups, with distant metastases more frequently found in group A. The results showing a significant improvement in lymph node control with postoperative radiotherapy, this adjuvant therapy is used systematically in this center in patients being operated on for hypopharyngeal and laryngeal cancer with incomplete histologically defined resection and/or with lymph nodes histologically involved.
AuthorsR Arriagada, F Eschwege, Y Cachin, J M Richard
JournalCancer (Cancer) Vol. 51 Issue 10 Pg. 1819-25 (May 15 1983) ISSN: 0008-543X [Print] United States
PMID6831347 (Publication Type: Journal Article)
Topics
  • Carcinoma, Squamous Cell (radiotherapy, secondary, surgery, therapy)
  • Female
  • Humans
  • Hypopharynx (surgery)
  • Laryngeal Neoplasms (radiotherapy, surgery, therapy)
  • Male
  • Neoplasm Recurrence, Local
  • Pharyngeal Neoplasms (radiotherapy, surgery, therapy)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: